50% off Premium Yearly
Speculative, but we need more pharma companies to make immunotherapy drugs.
Stock price when the opinion was issued
As of Jun 12, 2026. Market Open.
He likes their model, and there is no demand for their products.
Build your watch list
Sign in to track investmentsyou care about
CNBC
RN Croft Financial Group
5i Research
Stockchase Premium
Private Wealth Management, ScotiaMcleod
Speculative, but we need more pharma companies to make immunotherapy drugs.